12 July 2021 July 2021 decisions news release SMC accepts three new medicines for use by NHSScotland The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday 12 July) published advice accepting three new medicines.
11 June 2021 Ultra Orphan Validation Process SMC Executive has recently agreed an update to the ultra-orphan validation process such that from 1st September, ultra-orphan validation decisions will expire after 2 years. Thereafter if a product has MHRA marketing authorisation; if there are eligible patients in NHSScotland; and if no submission
7 June 2021 June 2021 decisions news release Five new medicines accepted for use by SMC Advice on five new medicines for use in conditions including advanced gastric cancer and chronic lymphocytic leukaemia has today (Monday 7 June) been published by the Scottish Medicines Consortium.
10 May 2021 May 2021 decisions news release Medicines for colorectal cancer, skin Medicines for colorectal cancer, skin cancer and ovarian cancer among four accepted for use by NHSScotlandcancer and ovarian cancer among four accepted for use by NHSScotland The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has announced today (Monday 10 May) that it has accepted four new medicines for routine use.
7 May 2021 Pilot of new health technology evaluation process for antimicrobials SMC announce pilot of new health technology evaluation process for antimicrobials.
12 April 2021 April 2021 decisions news release Advice on four new medicines published Advice on four new medicines for use in conditions including multiple myeloma and severe migraine has today (Monday 12 April) been published by the Scottish Medicines Consortium. A new medicine for Duchenne Muscular Dystrophy has now also been included in the ultra-orphan pathway.
31 March 2021 Two more COVID-19 treatments available through UK-wide initiative involving SMC Two more medicines can now be used to treat COVID-19, thanks to a UK-wide multi-agency initiative involving the Scottish Medicines Consortium (SMC).
8 March 2021 March 2021 decisions news release SMC accepts medicines for rare genetic disease in children and cancer tumours with genetic abnormality. Medicines which can be used to treat a rare genetic disease in children and some cancer tumours with a genetic abnormality have today (Monday 8 March) been accepted by the Scottish Medicines Consortium (SMC) for use by NHSScotland.
8 February 2021 February 2021 decisions news release SMC accepts four new medicines for use by NHSScotland The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has today (Monday 8 February) published advice on four new medicines.
